Catalase‐Based Therapeutics: An Antioxidant Enzyme Therapeutic for COVID‐19 (Adv. Mater. 43/2020). Issue 43 (26th October 2020)

• Record Type: Journal Article
• Authors: Qin, Meng; Cao, Zheng; Wen, Jing; Yu, Qingsong; Liu, Chaoyong; Wang, Fang; Zhang, Jianjun; Yang, Fengmei; Li, Yanyan; Fishbein, Gregory; Yan, Sen; Xu, Bin; Hou, Yi; Ning, Zhenbo; Nie, Kaili; Jiang, Ni; Liu, Zhen; Wu, Jun; Yu, Yanting; Li, Heng; Zheng, Huiwen; Li, Jing; Jin, Weihua; Pang, Shen; Wang, Shuai; Chen, Jianfeng; Gan, Zhihua; He, Zhanlong; Lu, Yunfeng
• Is Part Of: Advanced materials. Volume 32:Issue 43(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-10-26
• Subjects: anti‐inflammation -- catalase -- immunosuppression -- SARS‐Cov‐2; Materials -- Periodicals; Chemical vapor deposition -- Periodicals; 620.11
• DOI: 10.1002/adma.202070321
• Languages: English
• ISSNs: 0935-9648

Abstract

Abstract : In article number 2004901, Jianfeng Chen, Zhihua Gan, Zhanlong He, Yunfeng Lu, and co‐workers report an antioxidant enzyme therapeutic for COVID‐19. They demonstrate that catalase, a naturally occurring enzyme commonly used worldwide in food production and as a dietary supplement, can effectively suppress the replication of coronavirus, regulate production of cytokines, and protect lung tissues from oxidative injury.